Brain, Vol 120, Issue 6 1085-1096, Copyright © 1997 by Oxford University Press
AJ Thompson, CH Polman, DH Miller, WI McDonald, B Brochet, X Filippi M Montalban and J De Sa
Patients with multiple sclerosis who develop progressive disability from
onset without relapses or remissions pose difficulties in diagnosis,
monitoring of disease activity and treatment. There is a need to define the
diagnostic criteria for this group more precisely and, in particular, to
describe a comprehensive battery of investigations to exclude other
conditions. The mechanisms underlying the development of disability and the
role of MRI in monitoring disease activity in this clinical subgroup
require elucidation, particularly in view of the lack of change on
conventional imaging in the presence of continuing clinical deterioration.
The prognosis is poor and there are currently no treatment trials for this
form of the disease.
REVIEWS
Primary progressive multiple sclerosis
Department of Clinical Neurology, Institute of Neurology, London, UK.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
X. Montalban, J. Sastre-Garriga, M. Tintore, L. Brieva, F. Aymerich, J. Rio, J. Porcel, C. Borras, C. Nos, and A. Rovira A single-center, randomized, double-blind, placebo-controlled study of interferon beta-1b on primary progressive and transitional multiple sclerosis Multiple Sclerosis, October 1, 2009; 15(10): 1195 - 1205. [Abstract] [PDF] |
||||
![]() |
M Ukkonen, T Vahvelainen, P Hamalainen, P Dastidar, and I Elovaara Cognitive dysfunction in primary progressive multiple sclerosis: a neuropsychological and MRI study Multiple Sclerosis, September 1, 2009; 15(9): 1055 - 1061. [Abstract] [PDF] |
||||
![]() |
P Sundstrom and L Nystrom Smoking worsens the prognosis in multiple sclerosis Multiple Sclerosis, September 1, 2008; 14(8): 1031 - 1035. [Abstract] [PDF] |
||||
![]() |
Z Sternberg, B Weinstock-Guttman, D Hojnacki, P Zamboni, R Zivadinov, K Chadha, A Lieberman, L Kazim, A Drake, P Rocco, et al. Soluble receptor for advanced glycation end products in multiple sclerosis: A potential marker of disease severity Multiple Sclerosis, July 1, 2008; 14(6): 759 - 763. [Abstract] [PDF] |
||||
![]() |
M. Rovaris, E. Judica, J. Sastre-Garriga, A. Rovira, M. Pia Sormani, B. Benedetti, T. Korteweg, N. De Stefano, Z. Khaleeli, X. Montalban, et al. Large-scale, multicentre, quantitative MRI study of brain and cord damage in primary progressive multiple sclerosis Multiple Sclerosis, May 1, 2008; 14(4): 455 - 464. [Abstract] [PDF] |
||||
![]() |
J. Zwemmer, J. Bot, B. Jelles, F. Barkhof, and C. Polman At the heart of primary progressive multiple sclerosis: three cases with diffuse MRI abnormalities only Multiple Sclerosis, April 1, 2008; 14(3): 428 - 430. [Abstract] [PDF] |
||||
![]() |
C. Di Perri, M. Battaglini, M. L. Stromillo, M. L. Bartolozzi, L. Guidi, A. Federico, and N. De Stefano Voxel-Based Assessment of Differences in Damage and Distribution of White Matter Lesions Between Patients With Primary Progressive and Relapsing-Remitting Multiple Sclerosis Arch Neurol, February 1, 2008; 65(2): 236 - 243. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.R. Sajja, P.A. Narayana, J.S. Wolinsky, C.W. Ahn, and t. P. T. M. G. N/A Longitudinal magnetic resonance spectroscopic imaging of primary progressive multiple sclerosis patients treated with glatiramer acetate: multicenter study Multiple Sclerosis, January 1, 2008; 14(1): 73 - 80. [Abstract] [PDF] |
||||
![]() |
M. Ukkonen, X. Wu, B. Reipert, P. Dastidar, and I. Elovaara Cell surface adhesion molecules and cytokine profiles in primary progressive multiple sclerosis Multiple Sclerosis, July 1, 2007; 13(6): 701 - 707. [Abstract] [PDF] |
||||
![]() |
L. F. Barcellos, S. Sawcer, P. P. Ramsay, S. E. Baranzini, G. Thomson, F. Briggs, B. C.A. Cree, A. B. Begovich, P. Villoslada, X. Montalban, et al. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis Hum. Mol. Genet., September 15, 2006; 15(18): 2813 - 2824. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Tellez, M. Comabella, E v. Julia, J. Rio, M a. Tintore, L. Brieva, C. Nos, and X. Montalban Fatigue in progressive multiple sclerosis is associated with low levels of dehydroepiandrosterone Multiple Sclerosis, August 1, 2006; 12(4): 487 - 494. [Abstract] [PDF] |
||||
![]() |
J S Sloka, W E. Pryse-Phillips, and M Stefanelli The relation between menarche and the age of first symptoms in a multiple sclerosis cohort Multiple Sclerosis, June 1, 2006; 12(3): 333 - 339. [Abstract] [PDF] |
||||
![]() |
R. M. Burwick, P. P. Ramsay, J. L. Haines, S. L. Hauser, J. R. Oksenberg, M. A. Pericak-Vance, S. Schmidt, A. Compston, S. Sawcer, R. Cittadella, et al. APOE epsilon variation in multiple sclerosis susceptibility and disease severity: Some answers Neurology, May 9, 2006; 66(9): 1373 - 1383. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kremenchutzky, G. P. A. Rice, J. Baskerville, D. M. Wingerchuk, and G. C. Ebers The natural history of multiple sclerosis: a geographically based study 9: Observations on the progressive phase of the disease Brain, March 1, 2006; 129(3): 584 - 594. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Confavreux and S. Vukusic Natural history of multiple sclerosis: a unifying concept Brain, March 1, 2006; 129(3): 606 - 616. [Abstract] [Full Text] [PDF] |
||||
![]() |
L Ramio-Torrenta, J Sastre-Garriga, G T Ingle, G R Davies, V Ameen, D H Miller, and A J Thompson Abnormalities in normal appearing tissues in early primary progressive multiple sclerosis and their relation to disability: a tissue specific magnetisation transfer study J. Neurol. Neurosurg. Psychiatry, January 1, 2006; 77(1): 40 - 45. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rovaris, A. Gass, R. Bammer, S. J. Hickman, O. Ciccarelli, D. H. Miller, and M. Filippi Diffusion MRI in multiple sclerosis Neurology, November 22, 2005; 65(10): 1526 - 1532. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kutzelnigg, C. F. Lucchinetti, C. Stadelmann, W. Bruck, H. Rauschka, M. Bergmann, M. Schmidbauer, J. E. Parisi, and H. Lassmann Cortical demyelination and diffuse white matter injury in multiple sclerosis Brain, November 1, 2005; 128(11): 2705 - 2712. [Abstract] [Full Text] [PDF] |
||||
![]() |
G T Ingle, J Sastre-Garriga, D H Miller, and A J Thompson Is inflammation important in early PPMS? a longitudinal MRI study J. Neurol. Neurosurg. Psychiatry, September 1, 2005; 76(9): 1255 - 1258. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sastre-Garriga, G. T. Ingle, M. Rovaris, N. Tellez, B. Jasperse, D. R. Altmann, B. Benedetti, V. L. Stevenson, M. Cercignani, S. M. Leary, et al. Long-term clinical outcome of primary progressive MS: Predictive value of clinical and MRI data Neurology, August 23, 2005; 65(4): 633 - 635. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Friese and L. Fugger Autoreactive CD8+ T cells in multiple sclerosis: a new target for therapy? Brain, August 1, 2005; 128(8): 1747 - 1763. [Abstract] [Full Text] [PDF] |
||||
![]() |
H Zephir, J de Seze, K Dujardin, G Dubois, M Cabaret, S Bouillaguet, D Ferriby, T Stojkovic, and P Vermersch One-year cyclophosphamide treatment combined with methylprednisolone improves cognitive dysfunction in progressive forms of multiple sclerosis Multiple Sclerosis, June 1, 2005; 11(3): 360 - 363. [Abstract] [PDF] |
||||
![]() |
M. Rovaris, A. Gallo, A. Falini, B. Benedetti, P. Rossi, M. Comola, G. Scotti, G. Comi, and M. Filippi Axonal Injury and Overall Tissue Loss Are Not Related in Primary Progressive Multiple Sclerosis Arch Neurol, June 1, 2005; 62(6): 898 - 902. [Abstract] [Full Text] [PDF] |
||||
![]() |
S M Leary, B Porter, and A J Thompson Multiple sclerosis: diagnosis and the management of acute relapses Postgrad. Med. J., May 1, 2005; 81(955): 302 - 308. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sastre-Garriga, G. T. Ingle, D. T. Chard, Li. Ramio-Torrenta, M. A. McLean, D. H. Miller, and A. J. Thompson Metabolite Changes in Normal-Appearing Gray and White Matter Are Linked With Disability in Early Primary Progressive Multiple Sclerosis Arch Neurol, April 1, 2005; 62(4): 569 - 573. [Abstract] [Full Text] [PDF] |
||||
![]() |
F Agosta, M Rovaris, B Benedetti, P Valsasina, M Filippi, and G Comi Diffusion tensor MRI of the cervical cord in a patient with syringomyelia and multiple sclerosis J. Neurol. Neurosurg. Psychiatry, November 1, 2004; 75(11): 1647 - 1647. [Full Text] [PDF] |
||||
![]() |
J Oh, R G Henry, C Genain, S J Nelson, and D Pelletier Mechanisms of normal appearing corpus callosum injury related to pericallosal T1 lesions in multiple sclerosis using directional diffusion tensor and 1H MRS imaging J. Neurol. Neurosurg. Psychiatry, September 1, 2004; 75(9): 1281 - 1286. [Abstract] [Full Text] [PDF] |
||||
![]() |
J Sastre-Garriga, M Comabella, L Brieva, A Rovira, M Tintore, and X Montalban Decreased MMP-9 production in primary progressive multiple sclerosis patients Multiple Sclerosis, August 1, 2004; 10(4): 376 - 380. [Abstract] [PDF] |
||||
![]() |
M J Tullman, R J Oshinsky, F D Lublin, and G R Cutter Clinical characteristics of progressive relapsing multiple sclerosis Multiple Sclerosis, August 1, 2004; 10(4): 451 - 454. [Abstract] [PDF] |
||||
![]() |
A. Thompson Overview of primary progressive multiple sclerosis (PPMS): similarities and differences from other forms of MS, diagnostic criteria, pros and cons of progressive diagnosis Multiple Sclerosis, June 1, 2004; 10(1_suppl): S2 - S7. [Abstract] [PDF] |
||||
![]() |
G. C Ebers Natural history of primary progressive multiple sclerosis Multiple Sclerosis, June 1, 2004; 10(1_suppl): S8 - S15. [Abstract] [PDF] |
||||
![]() |
C. Lucchinetti and W. Bruck The pathology of primary progressive multiple sclerosis Multiple Sclerosis, June 1, 2004; 10(1_suppl): S23 - S30. [Abstract] [PDF] |
||||
![]() |
M. Filippi, M. Rovaris, and M. A Rocca Imaging primary progressive multiple sclerosis: the contribution of structural, metabolic, and functional MRI techniques Multiple Sclerosis, June 1, 2004; 10(1_suppl): S36 - S45. [Abstract] [PDF] |
||||
![]() |
M. P. Crawford, S. X. Yan, S. B. Ortega, R. S. Mehta, R. E. Hewitt, D. A. Price, P. Stastny, D. C. Douek, R. A. Koup, M. K. Racke, et al. High prevalence of autoreactive, neuroantigen-specific CD8+ T cells in multiple sclerosis revealed by novel flow cytometric assay Blood, June 1, 2004; 103(11): 4222 - 4231. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Thompson Overview of primary progressive multiple sclerosis (PPMS): similarities and differences from other forms of MS, diagnostic criteria, pros and cons of progressive diagnosis Multiple Sclerosis, May 1, 2004; 10(3_suppl): S2 - S7. [Abstract] [PDF] |
||||
![]() |
G. C Ebers Natural history of primary progressive multiple sclerosis Multiple Sclerosis, May 1, 2004; 10(3_suppl): S8 - S15. [Abstract] [PDF] |
||||
![]() |
C. Lucchinetti and W. Bruck The pathology of primary progressive multiple sclerosis Multiple Sclerosis, May 1, 2004; 10(3_suppl): S23 - S30. [Abstract] [PDF] |
||||
![]() |
M. Filippi, M. Rovaris, and M. A Rocca Imaging primary progressive multiple sclerosis: the contribution of structural, metabolic, and functional MRI techniques Multiple Sclerosis, May 1, 2004; 10(3_suppl): S36 - S45. [Abstract] [PDF] |
||||
![]() |
K. Schmierer, D. R Altmann, N. Kassim, H. Kitzler, C. M Kerskens, C. A Doege, O. Aktas, J. D Lunemann, D. H Miller, F. Zipp, et al. Progressive change in primary progressive multiple sclerosis normal-appearing white matter: a serial diffusion magnetic resonance imaging study Multiple Sclerosis, April 1, 2004; 10(2): 182 - 187. [Abstract] [PDF] |
||||
![]() |
G. T. Ingle, V. L. Stevenson, D. H. Miller, and A. J. Thompson Primary progressive multiple sclerosis: a 5-year clinical and MR study Brain, November 1, 2003; 126(11): 2528 - 2536. [Abstract] [Full Text] [PDF] |
||||
![]() |
D Pelletier, S J Nelson, J Oh, J P Antel, M Kita, S S Zamvil, and D E Goodkin MRI lesion volume heterogeneity in primary progressive MS in relation with axonal damage and brain atrophy J. Neurol. Neurosurg. Psychiatry, July 1, 2003; 74(7): 950 - 952. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. De Stefano, P. M. Matthews, M. Filippi, F. Agosta, M. De Luca, M. L. Bartolozzi, L. Guidi, A. Ghezzi, E. Montanari, A. Cifelli, et al. Evidence of early cortical atrophy in MS: Relevance to white matter changes and disability Neurology, April 8, 2003; 60(7): 1157 - 1162. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y Zoukos, T N Thomaides, D Kidd, M L Cuzner, and A Thompson Expression of {beta}2 adrenoreceptors on peripheral blood mononuclear cells in patients with primary and secondary progressive multiple sclerosis: a longitudinal six month study J. Neurol. Neurosurg. Psychiatry, February 1, 2003; 74(2): 197 - 202. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.M. Leary, D.H. Miller, V.L. Stevenson, P.A. Brex, D.T. Chard, and A.J. Thompson Interferon {beta}-1a in primary progressive MS: An exploratory, randomized, controlled trial Neurology, January 14, 2003; 60(1): 44 - 51. [Abstract] [Full Text] [PDF] |
||||
![]() |
M-L Sumelahti, P J Tienari, M Hakama, and J Wikstrom Multiple sclerosis in Finland: incidence trends and differences in relapsing remitting and primary progressive disease courses J. Neurol. Neurosurg. Psychiatry, January 1, 2003; 74(1): 25 - 28. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Riazi, J C Hobart, D L Lamping, R Fitzpatrick, and A J Thompson Multiple Sclerosis Impact Scale (MSIS-29): reliability and validity in hospital based samples J. Neurol. Neurosurg. Psychiatry, December 1, 2002; 73(6): 701 - 704. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Burks, B. G. Arnason, P. K. Coyle, C. C. Ford, A. Noronha, and K. W. Rammohan Issues and Practices in Multiple Sclerosis Neurorehabil Neural Repair, December 1, 2002; 16(4): 307 - 320. [Abstract] [PDF] |
||||
![]() |
K. Schmierer, K. Irlbacher, P. Grosse, S. Roricht, and B.-U. Meyer Correlates of disability in multiple sclerosis detected by transcranial magnetic stimulation Neurology, October 22, 2002; 59(8): 1218 - 1224. [Abstract] [Full Text] [PDF] |
||||
![]() |
E M Martinez-Caceres, C Espejo, L Brieva, I Pericot, M Tintore, I Saez-Torres, and X Montalban Expression of chemokine receptors in the different clinical forms of multiple sclerosis Multiple Sclerosis, October 1, 2002; 8(5): 390 - 395. [Abstract] [PDF] |
||||
![]() |
M. Rovaris, M. Bozzali, G. Iannucci, A. Ghezzi, D. Caputo, E. Montanari, A. Bertolotto, R. Bergamaschi, R. Capra, G. L. Mancardi, et al. Assessment of Normal-Appearing White and Gray Matter in Patients With Primary Progressive Multiple Sclerosis: A Diffusion-Tensor Magnetic Resonance Imaging Study Arch Neurol, September 1, 2002; 59(9): 1406 - 1412. [Abstract] [Full Text] [PDF] |
||||
![]() |
W Bruck, C Lucchinetti, and H Lassmann The pathology of primary progressive multiple sclerosis Multiple Sclerosis, April 1, 2002; 8(2): 93 - 97. [Abstract] [PDF] |
||||
![]() |
G T Ingle, V L Stevenson, D H Miller, S M Leary, M Rovaris, F Barkhof, B Brochet, V Dousset, M Filippi, X Montalban, et al. Two-year follow-up study of primary and transitional progressive multiple sclerosis Multiple Sclerosis, April 1, 2002; 8(2): 108 - 114. [Abstract] [PDF] |
||||
![]() |
M. A. Rocca, P. M. Matthews, D. Caputo, A. Ghezzi, A. Falini, G. Scotti, G. Comi, and M. Filippi Evidence for widespread movement-associated functional MRI changes in patients with PPMS Neurology, March 26, 2002; 58(6): 866 - 872. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rovaris, M. Bozzali, G. Santuccio, A. Ghezzi, D. Caputo, E. Montanari, A. Bertolotto, R. Bergamaschi, R. Capra, G. Mancardi, et al. In vivo assessment of the brain and cervical cord pathology of patients with primary progressive multiple sclerosis Brain, December 1, 2001; 124(12): 2540 - 2549. [Abstract] [Full Text] [PDF] |
||||
![]() |
G C Ebers NATURAL HISTORY OF MULTIPLE SCLEROSIS J. Neurol. Neurosurg. Psychiatry, December 1, 2001; 71(suppl_2): ii16 - ii19. [Full Text] [PDF] |
||||
![]() |
O. Neuhaus and H.-P. Hartung In search of a disease marker: the cytokine profile of primary progressive multiple sclerosis Multiple Sclerosis, June 1, 2001; 7(3): 143 - 144. [PDF] |
||||
![]() |
J Killestein, B F Den Drijver, W L Van der Graaff, B M. Uitdehaag, C H Polman, and R A. Van Lier Intracellular cytokine profile in T-cell subsets of multiple sclerosis patients: different features in primary progressive disease Multiple Sclerosis, June 1, 2001; 7(3): 145 - 150. [Abstract] [PDF] |
||||
![]() |
I Duran, E M Martinez-Caceres, L Brieva, M Tintore, and X Montalban Similar pro- and anti-inflammatory cytokine production in the different clinical forms of multiple sclerosis Multiple Sclerosis, June 1, 2001; 7(3): 151 - 156. [Abstract] [PDF] |
||||
![]() |
M. Cercignani, M. Inglese, E. Pagani, G. Comi, and M. Filippi Mean Diffusivity and Fractional Anisotropy Histograms of Patients with Multiple Sclerosis AJNR Am. J. Neuroradiol., May 1, 2001; 22(5): 952 - 958. [Abstract] [Full Text] |
||||
![]() |
M. Filippi, M. Cercignani, M. Inglese, M.A. Horsfield, and G. Comi Diffusion tensor magnetic resonance imaging in multiple sclerosis Neurology, February 13, 2001; 56(3): 304 - 311. [Abstract] [Full Text] [PDF] |
||||
![]() |
N.F. Kalkers, L. Bergers, V. de Groot, R.H.C. Lazeron, M.A.A. van Walderveen, B.M.J. Uitdehaag, C.H. Polman, and F. Barkhof Concurrent validity of the MS Functional Composite using MRI as a biological disease marker Neurology, January 23, 2001; 56(2): 215 - 219. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Comi, M. Leone, S. Bonissoni, S. DeFranco, F. Bottarel, C. Mezzatesta, A. Chiocchetti, F. Perla, F. Monaco, and U. Dianzani Defective T cell Fas function in patients with multiple sclerosis Neurology, October 10, 2000; 55(7): 921 - 927. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Butterfield, E. P. Blankenhorn, R. J. Roper, J. F. Zachary, R. W. Doerge, and C. Teuscher Identification of Genetic Loci Controlling the Characteristics and Severity of Brain and Spinal Cord Lesions in Experimental Allergic Encephalomyelitis Am. J. Pathol., August 1, 2000; 157(2): 637 - 645. [Abstract] [Full Text] [PDF] |
||||
![]() |
V L Stevenson, D H Miller, S M Leary, M Rovaris, F Barkhof, B Brochet, V Dousset, V Dousset, M Filippi, R Hintzen, et al. One year follow up study of primary and transitional progressive multiple sclerosis J. Neurol. Neurosurg. Psychiatry, June 1, 2000; 68(6): 713 - 718. [Abstract] [Full Text] [PDF] |
||||
![]() |
J Suhy, W D Rooney, D E Goodkin, A A Capizzano, B J Soher, A A Maudsley, E Waubant, P B Andersson, and M W Weiner 1H MRSI comparison of white matter and lesions in primary progressive and relapsing-remitting MS Multiple Sclerosis, June 1, 2000; 6(3): 148 - 155. [Abstract] [PDF] |
||||
![]() |
S. L. Hauser, J. R. Oksenberg, R. Lincoln, J. Garovoy, R. W. Beck, S. R. Cole, P. S. Moke, K. E. Kip, R. L. Gal, and D. T. Long Interaction between HLA-DR2 and abnormal brain MRI in optic neuritis and early MS Neurology, May 9, 2000; 54(9): 1859 - 1861. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Kremenchutzky, D Lee, G P A Rice, and G C Ebers Diagnostic brain MRI findings in primary progressive multiple sclerosis Multiple Sclerosis, April 1, 2000; 6(2): 81 - 85. [Abstract] [PDF] |
||||
![]() |
S J M WEATHERBY, C L A MANN, A A FRYER, R C STRANGE, C P HAWKINS, V L STEVENSON, S M LEARY, and A J THOMPSON Transverse myelopathy, a rare complication of mixed connective tissue disease: comparison with SLE related transverse myelopathy. J. Neurol. Neurosurg. Psychiatry, April 1, 2000; 68(4): 532 - 533. [Full Text] |
||||
![]() |
N. F. Kalkers, V. de Groot, R. H. C. Lazeron, J. Killestein, H. J. Ader, F. Barkhof, G. J. Lankhorst, and C. H. Polman MS Functional Composite: Relation to disease phenotype and disability strata Neurology, March 28, 2000; 54(6): 1233 - 1239. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Totaro, C. Marini, A. Cialfi, M. Giunta, and A. Carolei Prevalence of multiple sclerosis in the L'Aquila district, central Italy J. Neurol. Neurosurg. Psychiatry, March 1, 2000; 68(3): 349 - 352. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. C. Ebers, W. J. Koopman, W. Hader, A. D. Sadovnick, M. Kremenchutzky, P. Mandalfino, D. M. Wingerchuk, J. Baskerville, and G. P. A. Rice The natural history of multiple sclerosis: a geographically based study: 8: Familial multiple sclerosis Brain, March 1, 2000; 123(3): 641 - 649. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Tortorella, B. Viti, M. Bozzali, M. P. Sormani, G. Rizzo, M. F. Gilardi, G. Comi, and M. Filippi A magnetization transfer histogram study of normal-appearing brain tissue in MS Neurology, January 11, 2000; 54(1): 186 - 186. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Duran, E. M. Martinez-Caceres, J. Rio, N. Barbera, M. E. Marzo, and X. Montalban Immunological profile of patients with primary progressive multiple sclerosis: Expression of adhesion molecules Brain, December 1, 1999; 122(12): 2297 - 2307. [Abstract] [Full Text] [PDF] |
||||
![]() |
C H POLMAN, D H MILLER, W I MCDONALD, and A J THOMPSON Treatment recommendations for interferon-beta in multiple sclerosis J. Neurol. Neurosurg. Psychiatry, November 1, 1999; 67(5): 561 - 564. [Full Text] |
||||
![]() |
R.-B. Lindert, C. G. Haase, U. Brehm, C. Linington, H. Wekerle, and R. Hohlfeld Multiple sclerosis: B- and T-cell responses to the extracellular domain of the myelin oligodendrocyte glycoprotein Brain, November 1, 1999; 122(11): 2089 - 2100. [Abstract] [Full Text] [PDF] |
||||
![]() |
S M Leary, N C Silver, V L Stevenson, G J Barker, D H Miller, and A J Thompson Magnetisation transfer of normal appearing white matter in primary progressive multiple sclerosis Multiple Sclerosis, October 1, 1999; 5(5): 313 - 316. [Abstract] [PDF] |
||||
![]() |
M. A. Rocca, G. Mastronardo, M. A. Horsfield, C. Pereira, G. Iannucci, B. Colombo, L. Moiola, G. Comi, and M. Filippi Comparison of Three MR Sequences for the Detection of Cervical Cord Lesions in Patients with Multiple Sclerosis AJNR Am. J. Neuroradiol., October 1, 1999; 20(9): 1710 - 1716. [Abstract] [Full Text] |
||||
![]() |
P. B. Andersson, E. Waubant, L. Gee, and D. E. Goodkin Multiple Sclerosis That Is Progressive From the Time of Onset: Clinical Characteristics and Progression of Disability Arch Neurol, September 1, 1999; 56(9): 1138 - 1142. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Bashir and J. N. Whitaker Clinical and laboratory features of primary progressive and secondary progressive MS Neurology, September 1, 1999; 53(4): 765 - 765. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. T. Bergh, T. Kumpfel, C. Trenkwalder, R. Rupprecht, and F. Holsboer Dysregulation of the hypothalamo-pituitary-adrenal axis is related to the clinical course of MS Neurology, September 1, 1999; 53(4): 772 - 772. [Abstract] [Full Text] [PDF] |
||||
![]() |
V L Stevenson and D H Miller Magnetic resonance imaging in the monitoring of disease progression in multiple sclerosis Multiple Sclerosis, August 1, 1999; 5(4): 268 - 272. [Abstract] [PDF] |
||||
![]() |
M. Filippi, C. Tortorella, and M. Bozzali Normal-appearing white matter changes in multiple sclerosis: the contribution of magnetic resonance techniques Multiple Sclerosis, August 1, 1999; 5(4): 273 - 282. [Abstract] [PDF] |
||||
![]() |
G. Mastronardo, M. A. Rocca, G. Iannucci, C. Pereira, and M. Filippi A Longitudinal MR Study of the Presymptomatic Phase in a Patient with Clinically Definite Multiple Sclerosis AJNR Am. J. Neuroradiol., August 1, 1999; 20(7): 1268 - 1272. [Abstract] [Full Text] |
||||
![]() |
F. Fazekas, F. Barkhof, M. Filippi, R. I. Grossman, D. K. B. Li, W. I. McDonald, H. F. McFarland, D. W. Paty, J. H. Simon, J. S. Wolinsky, et al. The contribution of magnetic resonance imaging to the diagnosis of multiple sclerosis Neurology, August 1, 1999; 53(3): 448 - 448. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Camp, V. L. Stevenson, A. J. Thompson, D. H. Miller, C. Borras, S. Auriacombe, B. Brochet, M. Falautano, M. Filippi, L. Herisse-Dulo, et al. Cognitive function in primary progressive and transitional progressive multiple sclerosis: A controlled study with MRI correlates Brain, July 1, 1999; 122(7): 1341 - 1348. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Cottrell, M. Kremenchutzky, G. P. A. Rice, W. Hader, J. Baskerville, and G. C. Ebers The natural history of multiple sclerosis: a geographically based study: 6. Applications to planning and interpretation of clinical therapeutic trials in primary progressive multiple sclerosis Brain, April 1, 1999; 122(4): 641 - 647. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. L. Stevenson, D. H. Miller, M. Rovaris, F. Barkhof, B. Brochet, V. Dousset, V. Dousset, M. Filippi, X. Montalban, C. H. Polman, et al. Primary and transitional progressive MS: A clinical and MRI cross-sectional study Neurology, March 1, 1999; 52(4): 839 - 839. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Filippi, G. Iannucci, C. Tortorella, L. Minicucci, M. A. Horsfield, B. Colombo, M. P. Sormani, and G. Comi Comparison of MS clinical phenotypes using conventional and magnetization transfer MRI Neurology, February 1, 1999; 52(3): 588 - 588. [Abstract] [Full Text] [PDF] |
||||
![]() |
G Giovannoni, A J. Green, and E J Thompson Are there any body fluid markers of brain atrophy in multiple sclerosis? Multiple Sclerosis, June 1, 1998; 4(3): 138 - 142. [Abstract] [PDF] |
||||
![]() |
G V McDonnell and S A Hawkins Clinical study of primary progressive multiple sclerosis in Northern Ireland, UK J. Neurol. Neurosurg. Psychiatry, April 1, 1998; 64(4): 451 - 454. [Abstract] [Full Text] [PDF] |
||||










